[1]
Farheen B. Mujawar et al. 2025. “ROLE OF INFLAMMATORY MARKERS CRP AND FERRITIN IN PANCREATIC DUCTAL ADENOCARCINOMA”. Journal of Population Therapeutics and Clinical Pharmacology. 32, 10 (Dec. 2025), 1830–1834. DOI:https://doi.org/10.53555/zyy8dz85.